Cargando…
SARS-CoV-2 Vaccine Development: An Overview and Perspectives
[Image: see text] Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It started in late December 2019 in Wuhan, China, and by mid-March 2020, the disease had spread globally. As of July 17,...
Autores principales: | Liu, Yi, Wang, Kai, Massoud, Tarik F., Paulmurugan, Ramasamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526333/ https://www.ncbi.nlm.nih.gov/pubmed/33062951 http://dx.doi.org/10.1021/acsptsci.0c00109 |
Ejemplares similares
-
A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography
por: Massoud, Tarik F., et al.
Publicado: (2010) -
Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis
por: Kumar, Nita, et al.
Publicado: (2018) -
The SARS-CoV-2 Vaccine Pipeline: an Overview
por: Chen, Wen-Hsiang, et al.
Publicado: (2020) -
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
por: Jugniot, Natacha, et al.
Publicado: (2022) -
A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models
por: Sadeghipour, Negar, et al.
Publicado: (2022)